BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16915276)

  • 1. Cancer biology: a game of subversion.
    Passegué E
    Nature; 2006 Aug; 442(7104):754-5. PubMed ID: 16915276
    [No Abstract]   [Full Text] [Related]  

  • 2. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.
    Krivtsov AV; Twomey D; Feng Z; Stubbs MC; Wang Y; Faber J; Levine JE; Wang J; Hahn WC; Gilliland DG; Golub TR; Armstrong SA
    Nature; 2006 Aug; 442(7104):818-22. PubMed ID: 16862118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?
    Muntean AG; Hess JL
    Cancer Cell; 2008 Jun; 13(6):465-7. PubMed ID: 18538728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis.
    Daser A; Rabbitts TH
    Semin Cancer Biol; 2005 Jun; 15(3):175-88. PubMed ID: 15826832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene regulation in normal and leukaemic progenitor/stem cells.
    De Maria R; Grignani F; Testa U; Valtieri M; Ziegler BL; Peschle C
    Haematologica; 1999 Jun; 84 Suppl EHA-4():8-10. PubMed ID: 10907455
    [No Abstract]   [Full Text] [Related]  

  • 6. Mixed lineage leukemia translocations and a leukemia stem cell program.
    Faber J; Armstrong SA
    Cancer Res; 2007 Sep; 67(18):8425-8. PubMed ID: 17875678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When speed matters: leukemogenic transformation by MLL fusion proteins.
    Slany RK
    Cell Cycle; 2010 Jul; 9(13):2475-6. PubMed ID: 20543578
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined effects of the two reciprocal t(4;11) fusion proteins MLL.AF4 and AF4.MLL confer resistance to apoptosis, cell cycling capacity and growth transformation.
    Gaussmann A; Wenger T; Eberle I; Bursen A; Bracharz S; Herr I; Dingermann T; Marschalek R
    Oncogene; 2007 May; 26(23):3352-63. PubMed ID: 17130830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the initiation and progression of human acute leukemia in mice.
    Barabé F; Kennedy JA; Hope KJ; Dick JE
    Science; 2007 Apr; 316(5824):600-4. PubMed ID: 17463288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation from committed progenitor to leukemia stem cells.
    Krivtsov AV; Feng Z; Armstrong SA
    Ann N Y Acad Sci; 2009 Sep; 1176():144-9. PubMed ID: 19796242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cells refined.
    Scadden DT
    Nat Immunol; 2004 Jul; 5(7):701-3. PubMed ID: 15224098
    [No Abstract]   [Full Text] [Related]  

  • 12. Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype.
    Santillan DA; Theisler CM; Ryan AS; Popovic R; Stuart T; Zhou MM; Alkan S; Zeleznik-Le NJ
    Cancer Res; 2006 Oct; 66(20):10032-9. PubMed ID: 17047066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trithorax group genes in hematopoiesis.
    Chase J; Grembecka J; Maillard I
    Oncotarget; 2015 Jul; 6(20):17855-6. PubMed ID: 26257003
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor.
    Hirose K; Abramovich C; Argiropoulos B; Humphries RK
    Oncogene; 2008 Oct; 27(46):6056-67. PubMed ID: 18604245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cells: good, bad and reformable.
    Janzen V; Scadden DT
    Nature; 2006 May; 441(7092):418-9. PubMed ID: 16724049
    [No Abstract]   [Full Text] [Related]  

  • 16. Leukaemia: niche retreats for stem cells.
    Williams DA; Cancelas JA
    Nature; 2006 Dec; 444(7121):827-8. PubMed ID: 17167463
    [No Abstract]   [Full Text] [Related]  

  • 17. Bilineage acute leukemia of T-lymphoid and myeloid lineages.
    Kobayashi N; Matsuda K; Sakashita K; Matsuzaki S; Iwasaki R; Koike K
    Haematologica; 2004 Sep; 89(9):1139-41. PubMed ID: 15377477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant dendritic cell differentiation initiated by the Mll-Een fusion gene does not require leukemic transformation.
    Sun Q; Kong CT; Huang FP; Chan LC
    J Leukoc Biol; 2008 Jan; 83(1):173-80. PubMed ID: 17895399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression.
    Yamaguchi H; Hanawa H; Uchida N; Inamai M; Sawaguchi K; Mitamura Y; Shimada T; Dan K; Inokuchi K
    Exp Hematol; 2009 Jun; 37(6):701-14. PubMed ID: 19463771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute megakaryoblastic leukemia in a child with the MLL-AF4 fusion gene.
    Takita J; Motomura A; Koh K; Ida K; Taki T; Hayashi Y; Igarashi T
    Eur J Haematol; 2009 Aug; 83(2):149-53. PubMed ID: 19459927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.